HUM:NYE-Humana Inc. (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 352.43

Change

-1.02 (-0.29)%

Market Cap

USD 30.56B

Volume

0.60M

Analyst Target

USD 448.08
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Humana Inc is a health care company that offers insurance products and health and wellness services. Its segments include Retail, Employer Group and Healthcare Services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

+5.90 (+1.00%)

USD 553.16B
ELV Elevance Health Inc

+4.99 (+0.91%)

USD 126.07B
CNC Centene Corp

+0.53 (+0.71%)

USD 37.35B
MOH Molina Healthcare Inc

+5.26 (+1.49%)

USD 19.48B
OSCR Oscar Health Inc

+0.61 (+2.90%)

USD 4.11B
NEUE NeueHealth Inc

-0.20 (-3.57%)

USD 0.05B
CI Cigna Corp

+2.55 (+0.70%)

N/A
CVS CVS Health Corp

+0.45 (+0.78%)

N/A

ETFs Containing HUM

XSGI:LSE Xtrackers S&P Global Infr.. 3.83 % 0.00 %

+25.50 (+1.26%)

USD 0.25B
SSPX Janus Henderson U.S. Sust.. 3.67 % 0.00 %

+0.24 (+1.26%)

USD 8.63M
TUSB:CA TD Select U.S. Short Term.. 2.16 % 0.28 %

+0.03 (+1.26%)

CAD 8.43M
TUSB-U:CA TD Select U.S. Short Term.. 2.16 % 0.00 %

-0.02 (1.26%)

CAD 8.25M
SRHQ Elevation Series Trust - .. 1.84 % 0.00 %

+0.49 (+1.26%)

N/A
GVLU Tidal ETF Trust 0.53 % 0.00 %

+0.37 (+1.26%)

USD 0.16B
CVMC Morgan Stanley ETF Trust .. 0.50 % 0.00 %

+0.73 (+1.26%)

N/A
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.59 (+1.26%)

N/A
MUS:CA Mackenzie Maximum Diversi.. 0.00 % 0.58 %

+0.28 (+1.26%)

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

+1.36 (+1.26%)

N/A
DUSA 0.00 % 0.63 %

N/A

N/A
DWLD 0.00 % 0.64 %

N/A

N/A
VETS 0.00 % 0.60 %

N/A

N/A
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
LONG:CA CI Global Longevity Econo.. 0.00 % 0.00 %

N/A

CAD 3.67M
GBLO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -23.02% 25% F 8% B-
Dividend Return 0.39% 20% F 8% B-
Total Return -22.63% 25% F 8% B-
Trailing 12 Months  
Capital Gain -25.84% 13% F 9% A-
Dividend Return 0.74% 20% F 8% B-
Total Return -25.10% 13% F 8% B-
Trailing 5 Years  
Capital Gain 24.44% 33% F 57% F
Dividend Return 5.25% 25% F 15% F
Total Return 29.69% 33% F 50% F
Average Annual (5 Year Horizon)  
Capital Gain 6.04% 38% F 59% D-
Dividend Return 6.75% 50% F 54% F
Total Return 0.70% 40% F 16% F
Risk Return Profile  
Volatility (Standard Deviation) 20.26% 63% D 51% F
Risk Adjusted Return 33.29% 63% D 52% F
Market Capitalization 30.56B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 27.50 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector